Connecticut Towns With the Most PFAS Right Now: The Thyroid & Hair-Loss Angle

The Connecticut public-water towns carrying the most PFAS right now are Colchester (9.0 ng/L PFOS), Putnam (8.5 ng/L PFOA), and Manchester and Chester (6.9 ng/L PFOA) — all above the EPA's 4 ng/L limit, in water that carries a thyroid-relevant contaminant.

This is a current-readings ranking, not a historical one. For the full statewide PFAS picture — how many compounds each town has and how we built the broader list — see the full PFAS ranking. This post does something narrower: it ranks by the single highest PFAS reading on file right now against the new federal limit, and reads that through the thyroid-and-hair-loss lens. Every reading below shows its measurement date so you can see it is current.

The 12 Connecticut Towns With the Highest Current PFAS

The EPA finalized enforceable limits in 2024: 4 ng/L (parts per trillion) for PFOA and for PFOS, with 10 ng/L for PFHxS and PFNA. Utilities must comply by 2029 (EPA PFAS). The readings below are finished-water results from 2023 through 2025 — current, not legacy — ranked by how far the highest single compound sits above that 4 ng/L line.

Source: CheckYourTap water quality data, 2026 (current EPA compliance readings, finished water). Twenty-five Connecticut public-water towns currently exceed the 4 ng/L limit; these are the top 12.

One honest note about the bottom of the table: towns nine through twelve sit at 4.3 ng/L — about 1.08× the limit, a marginal exceedance. That still counts as over the line and still has to be fixed by 2029, but it is a genuinely different situation from Colchester's 9.0 ng/L. We would rather say that plainly than dramatize a reading that is a rounding error above the threshold.

How PFAS Reaches the Thyroid

PFAS compounds are endocrine disruptors, and the thyroid is one of their documented targets. The clearest population signal comes from a 2010 NHANES analysis: women in the highest quartile of serum PFOA had roughly double the odds of thyroid disease (odds ratio 2.2, 95% confidence interval 1.4–3.7) compared with the lowest quartiles. That is an association across a population, not proof that PFOA caused any individual case — but it is a real, statistically significant signal concentrated in the most-exposed group.

How large is the underlying hormone effect? A 2025 study of a PFAS-exposed community published in Scientific Reports found that a higher PFAS mixture was associated with only about a 2 percent decrease in total T3 — a small, subclinical shift, not overt thyroid failure. Hold onto that number; it is the pivot the rest of this post turns on.

PFOA and PFOS are the two compounds driving this ranking, and they are the two the EPA capped most tightly. If you want the contaminant-level detail, see the hub pages for PFOA and PFOS.

Does That Mean These Towns Cause Hair Loss? (The Honest Gap)

No — and this is where careful language matters. Thyroid dysfunction, specifically overt hypothyroidism, is one of the most common causes of diffuse hair loss (telogen effluvium). A 2024 study of telogen-effluvium patients quantified it: those with overt hypothyroidism had substantially more severe shedding than those with normal thyroid function. That link is solid.

The gap is in the middle. PFAS at these town levels is associated with small, subclinical thyroid hormone shifts — that 2 percent T3 change — while the hair-loss evidence comes from people with diagnosed, overt hypothyroidism, a far more severe state. Connecting "9.0 ng/L PFOS in Colchester's water" to "hair loss in Colchester" requires walking a chain of plausible but unproven steps: water exposure → serum accumulation → a small hormone shift → a clinically meaningful thyroid state → shedding. Each link has support; the full chain, at these exposure levels, is a plausibility, not a demonstrated cause.

So read this ranking for what it is: these are the Connecticut towns whose water carries the most of a thyroid-relevant contaminant right now — not a list of towns that cause baldness. For the deeper mechanism and what a doctor can test, see PFAS, thyroid disease, and hair loss. PFAS is not the only thyroid-relevant contaminant in Connecticut water, either; perchlorate does something similar by a different route.

What These Towns Can Do

The 2024 rule gives utilities until 2029 to comply, and the fixes are known: granular activated carbon, ion exchange, or reverse-osmosis treatment at the plant. That is the town-scale answer. At the household scale, a point-of-use reverse-osmosis filter removes PFAS along with most other dissolved contaminants — a reasonable step if your address reads above the limit and you would rather not wait on the compliance timeline.

This is where our approach differs from a single national number. The EPA's 4 ng/L is a legal limit, weighed against cost and feasibility for a whole water system. CheckYourTap reports what is actually in a specific place and compares it to health-based context, because a 9.0 ng/L reading and a 4.3 ng/L reading are not the same situation even though both are "over the limit." We are deliberately more granular than one-size-fits-all guidance — currently personalized for Connecticut, and expanding.

Keep Reading

• The full Connecticut PFAS ranking — every town, every compound
• PFAS, thyroid disease, and hair loss: the mechanism
• Perchlorate in tap water — the other thyroid-relevant contaminant
• What reverse osmosis removes from Connecticut water

Sources: U.S. EPA, PFAS National Primary Drinking Water Regulation, 2024 (enforceable limits of 4 ng/L for PFOA and PFOS; compliance by 2029), epa.gov/pfas; Melzer D et al., serum PFOA and thyroid disease in NHANES, Environmental Health Perspectives, 2010, PMID 20089479; PFAS mixture and thyroid hormones in an exposed community, Scientific Reports, 2025, s41598-025-91977-y; Dayel SB et al., thyroid status and telogen effluvium severity, 2024, PMID 38181279. Town readings are current finished-water compliance results from CheckYourTap water quality data, 2026. This is educational information, not medical advice — consult your provider.